Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels
Sponsor: Qualia Life Sciences
Summary
This is a randomized, double-blind, placebo-controlled parallel trial designed to evaluate the effectiveness of Qualia Magnesium+® supplementation on red blood cell (RBC) magnesium levels in adults aged 21 and older. Approximately 100 participants with baseline RBC magnesium levels below 6.0 mg/dL will be randomly assigned to receive either Qualia Magnesium+ or a placebo. Participants will take 2 capsules daily in the evening, with or without food, for a duration of 12 weeks. The primary outcome is the between-group change in RBC magnesium levels from baseline to Week 12. Secondary outcomes include assessments of sleep quality, perceived stress, magnesium status, and safety and tolerability. Data collection will occur through lab bloodwork and electronic questionnaires.
Official title: Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels: A Randomized Double-Blind Parallel Trial
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2025-05-21
Completion Date
2025-09-21
Last Updated
2025-05-20
Healthy Volunteers
Yes
Conditions
Interventions
Qualia Magnesium+®
Qualia Magnesium+® manufactured by Qualia Life Sciences
Placebo
Rice Flour
Locations (1)
Qualia Life Sciences
Carlsbad, California, United States